| [1] |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2021, 77(4):450-500.
|
| [2] |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7):561-632.
|
| [3] |
Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry[J]. J Am Coll Cardiol, 2013, 62(17):1552-1562.
|
| [4] |
Khatri PJ, Webb JG, Rodés-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies[J]. Ann Intern Med, 2013, 158(1):35-46.
|
| [5] |
Webb JG, Mack MJ, White JM, et al. Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 Valve-in-Valve Registry[J]. J Am Coll Cardiol, 2017, 69(18):2253-2262.
|
| [6] |
Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA[J]. JACC Cardiovasc Interv, 2019, 12(13):1197-1216.
|
| [7] |
Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR)[J]. J Cardiovasc Comput Tomogr, 2012, 6(6):366-380.
|
| [8] |
Holmes DR, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2012, 59(13):1200-1254.
|
| [9] |
Arai T, Lefèvre T, Hovasse T, et al. Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world[J]. Catheter Cardiovasc Interv, 2017, 90(7):1192-1197.
|
| [10] |
Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review[J]. JACC Cardiovasc Interv, 2013, 6(5):452-461.
|
| [11] |
Buellesfeld L, Stortecky S, Kalesan B, et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2013, 6(1):72-83.
|
| [12] |
Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2018, 71(14):1513-1524.
|
| [13] |
Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: a multicenter international registry[J]. JACC Cardiovasc Interv, 2020, 13(6):739-747.
|
| [14] |
Kleiman NS. Delayed coronary obstruction after TAVR: a call for vigilance[J]. J Am Coll Cardiol, 2018, 71(14):1525-1527.
|
| [15] |
Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR[J]. JACC Cardiovasc Interv, 2020, 13(6):693-705.
|
| [16] |
Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry[J]. Circulation, 2012, 126(19):2335-2344.
|
| [17] |
Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry[J]. Eur Heart J, 2018, 39(8):687-695.
|
| [18] |
Landes U, Witberg G, Sathananthan J, et al. Incidence, causes, and outcomes associated with urgent implantation of a supplementary valve during transcatheter aortic valve replacement[J]. JAMA Cardiol, 2021, 6(8):936-944.
|
| [19] |
Kitamura M, Wilde J, Dumpies O, et al. risk assessment of coronary obstruction during transcatheter aortic valve replacement: insights from Post-BASILICA computed tomography[J]. JACC Cardiovasc Interv, 2022, 15(5):496-507.
|
| [20] |
Sammour Y, Krishnaswamy A, Kumar A, et al. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2021, 14(2):115-134.
|
| [21] |
Reul RM, Ramchandani MK, Reardon MJ. Transcatheter aortic valve-in-valve procedure in patients with bioprosthetic structural valve deterioration[J]. Methodist Debakey Cardiovasc J, 2017, 13(3):132-141.
|
| [22] |
Montalto C, Sticchi A, Crimi G, et al. Outcomes after transcatheter aortic valve replacement in bicuspid versus tricuspid anatomy: a systematic review and Meta-nalysis[J]. JACC Cardiovasc Interv, 2021, 14(19):2144-2155.
|
| [23] |
Fan J, Fang X, Liu C, et al. Brain injury after transcatheter replacement of bicuspid versus tricuspid aortic valves[J]. J Am Coll Cardiol, 2020, 76(22):2579-2590.
|
| [24] |
Forrest JK, Ramlawi B, Deeb GM, et al. Transcatheter aortic valve replacement in low-risk patients with bicuspid aortic valve stenosis[J]. JAMA Cardiol, 2021, 6(1):50-57.
|
| [25] |
Yousef A, Simard T, Webb J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve: a patient level multi-center analysis[J]. Int J Cardiol, 2015, 189:282-288.
|
| [26] |
Yoon SH, Lefèvre T, Ahn JM, et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis[J]. J Am Coll Cardiol, 2016, 68(11):1195-1205.
|
| [27] |
He YX, Fan JQ, Zhu QF, et al. Ascending aortic dilatation rate after transcatheter aortic valve replacement in patients with bicuspid and tricuspid aortic stenosis: a multidetector computed tomography follow-up study[J]. World J Emerg Med, 2019, 10(4):197-204.
|
| [28] |
Chen F, Xiong T, Li Y, et al. Risk of coronary obstruction during redo-TAVR in patients with bicuspid versus tricuspid aortic valve stenosis[J]. JACC Cardiovasc Interv, 2022, 15(7):712-724.
|
| [29] |
Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2017, 10(14):1428-1435.
|
| [30] |
Durmaz T, Ayhan H, Keles T, et al. Left main coronary artery obstruction by dislodged native-valve calculus after transcatheter aortic valve replacement[J]. Tex Heart Inst J, 2014, 41(4):414-417.
|
| [31] |
Kubo S, Fuku Y, Shimamoto T, et al. Leaflet protrusion into left main coronary artery detected by intravascular ultrasound after transcatheter aortic valve implantation with SAPIEN 3[J]. Eur Heart J Cardiovasc Imaging, 2017, 18(5):608.
|
| [32] |
Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS Study[J]. JACC Cardiovasc Interv, 2020, 13(21):2542-2555.
|
| [33] |
Faroux L, Lhermusier T, Vincent F, et al. ST-Segment elevation myocardial infarction following transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2021, 77(17):2187-2199.
|
| [34] |
Alkhouli M, Al Mustafa A, Chaker Z, et al. Mechanical circulatory support in patients with severe aortic stenosis and left ventricular dysfunction undergoing percutaneous coronary intervention[J]. J Card Surg, 2017, 32(4):245-249.
|
| [35] |
Ripley B, Kelil T, Cheezum MK, et al. 3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement[J]. J Cardiovasc Comput Tomogr, 2016, 10(1):28-36.
|
| [36] |
Vincent F, Ternacle J, Denimal T, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis[J]. Circulation, 2021, 143(10):1043-1061.
|
| [37] |
Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis[J]. J Am Coll Cardiol, 2009, 54(4):303-311.
|
| [38] |
Mercanti F, Rosseel L, Neylon A, et al. Chimney stenting for coronary occlusion during TAVR: insights from the chimney registry[J]. JACC Cardiovasc Interv, 2020, 13(6):751-761.
|
| [39] |
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med, 2016, 374(17):1609-1620.
|
| [40] |
Rheude T, Pellegrini C, Lutz J, et al. Transcatheter aortic valve replacement with balloon-expandable valves: comparison of SAPIEN 3 Ultra Versus SAPIEN 3[J]. JACC Cardiovasc Interv, 2020, 13(22):2631-2638.
|
| [41] |
Abdelghani M, Landt M, Traboulsi H, et al. Coronary access after TAVR with a self-expanding bioprosthesis: insights from computed tomography[J]. JACC Cardiovasc Interv, 2020, 13(6):709-722.
|
| [42] |
Rogers T, Greenspun BC, Weissman G, et al. Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients[J]. JACC Cardiovasc Interv, 2020, 13(6):726-735.
|
| [43] |
Tang G, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap[J]. JACC Cardiovasc Interv, 2020, 13(9):1030-1042.
|